Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Beijing Tong Ren Tang Chinese Medicine Co ( (HK:3613) ) has provided an announcement.
Beijing Tong Ren Tang Chinese Medicine Co has announced the composition of its Board of Directors, highlighting the roles and functions of each member. This announcement provides clarity on the company’s governance structure, which may impact its strategic direction and reassure stakeholders about its leadership stability.
The most recent analyst rating on (HK:3613) stock is a Buy with a HK$10.50 price target. To see the full list of analyst forecasts on Beijing Tong Ren Tang Chinese Medicine Co stock, see the HK:3613 Stock Forecast page.
More about Beijing Tong Ren Tang Chinese Medicine Co
Beijing Tong Ren Tang Chinese Medicine Co is a company incorporated in Hong Kong, operating in the traditional Chinese medicine industry. It focuses on the production and distribution of Chinese medicinal products.
Average Trading Volume: 1,339,083
Technical Sentiment Signal: Buy
Current Market Cap: HK$7.57B
Find detailed analytics on 3613 stock on TipRanks’ Stock Analysis page.